Cargando…
Screening North American plant extracts in vitro against Trypanosoma brucei for discovery of new antitrypanosomal drug leads
BACKGROUND: Human African Trypanosomiasis (HAT) is a protozoan parasitic disease caused by Trypanosoma brucei. The disease is endemic in regions of sub-Saharan Africa, covering 36 countries and more than 60 million people at the risk. Only few drugs are available for the treatment of HAT. Current dr...
Autores principales: | Jain, Surendra, Jacob, Melissa, Walker, Larry, Tekwani, Babu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870785/ https://www.ncbi.nlm.nih.gov/pubmed/27193901 http://dx.doi.org/10.1186/s12906-016-1122-0 |
Ejemplares similares
-
Comparative Molecular Docking of Antitrypanosomal Natural Products into Multiple Trypanosoma brucei Drug Targets
por: Ogungbe, Ifedayo V., et al.
Publicado: (2009) -
Salvia officinalis L.: Antitrypanosomal Activity and Active Constituents against Trypanosoma brucei rhodesiense
por: Llurba Montesino, Núria, et al.
Publicado: (2021) -
Inhibitors of ubiquitin E3 ligase as potential new antimalarial drug leads
por: Jain, Jagrati, et al.
Publicado: (2017) -
From On-Target to Off-Target Activity: Identification and Optimisation of Trypanosoma brucei GSK3 Inhibitors and Their Characterisation as Anti-Trypanosoma brucei Drug Discovery Lead Molecules
por: Woodland, Andrew, et al.
Publicado: (2013) -
Evaluation of in vivo antitrypanosomal activity of crude extracts of Artemisia abyssinica against aTrypanosoma congolense isolate
por: Feyera, Teka, et al.
Publicado: (2014)